These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 21362193)

  • 1. Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis.
    Heininger A; Haeberle H; Fischer I; Beck R; Riessen R; Rohde F; Meisner C; Jahn G; Koenigsrainer A; Unertl K; Hamprecht K
    Crit Care; 2011; 15(2):R77. PubMed ID: 21362193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus reactivation in a general, nonimmunosuppressed intensive care unit population: incidence, risk factors, associations with organ dysfunction, and inflammatory biomarkers.
    Frantzeskaki FG; Karampi ES; Kottaridi C; Alepaki M; Routsi C; Tzanela M; Vassiliadi DA; Douka E; Tsaousi S; Gennimata V; Ilias I; Nikitas N; Armaganidis A; Karakitsos P; Papaevangelou V; Dimopoulou I
    J Crit Care; 2015 Apr; 30(2):276-81. PubMed ID: 25457114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Ganciclovir on IL-6 Levels Among Cytomegalovirus-Seropositive Adults With Critical Illness: A Randomized Clinical Trial.
    Limaye AP; Stapleton RD; Peng L; Gunn SR; Kimball LE; Hyzy R; Exline MC; Files DC; Morris PE; Frankel SK; Mikkelsen ME; Hite D; Enfield KB; Steingrub J; O'Brien J; Parsons PE; Cuschieri J; Wunderink RG; Hotchkin DL; Chen YQ; Rubenfeld GD; Boeckh M
    JAMA; 2017 Aug; 318(8):731-740. PubMed ID: 28829877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus reactivation in critically ill immunocompetent patients.
    Limaye AP; Kirby KA; Rubenfeld GD; Leisenring WM; Bulger EM; Neff MJ; Gibran NS; Huang ML; Santo Hayes TK; Corey L; Boeckh M
    JAMA; 2008 Jul; 300(4):413-22. PubMed ID: 18647984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus reactivation in immunocompetent mechanical ventilation patients: a prospective observational study.
    Zhang Z; Liu X; Sang L; Chen S; Wu Z; Zhang J; Sun Y; Huang Y; Xu Y; He W; Li Y; Liu X
    BMC Infect Dis; 2021 Sep; 21(1):1026. PubMed ID: 34592936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivation of multiple viruses in patients with sepsis.
    Walton AH; Muenzer JT; Rasche D; Boomer JS; Sato B; Brownstein BH; Pachot A; Brooks TL; Deych E; Shannon WD; Green JM; Storch GA; Hotchkiss RS
    PLoS One; 2014; 9(2):e98819. PubMed ID: 24919177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary herpes simplex virus and cytomegalovirus in patients with acute respiratory distress syndrome related to COVID-19.
    Boers LS; van Someren Gréve F; van Hattem JM; de Brabander J; Zwaan T; van Willigen H; Cornelissen M; de Jong M; van der Poll T; Duitman J; Schinkel J; Bos LDJ;
    Intensive Care Med; 2024 Aug; 50(8):1251-1264. PubMed ID: 39017695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-γ production by CMV-specific CD8+ T lymphocytes provides protection against cytomegalovirus reactivation in critically ill patients.
    Castón JJ; Cantisán S; González-Gasca F; Páez-Vega A; Abdel-Hadi H; Illescas S; Alonso G; Torre-Cisneros J
    Intensive Care Med; 2016 Jan; 42(1):46-53. PubMed ID: 26537489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between Pulmonary Aspergillosis and
    Caciagli V; Coloretti I; Talamonti M; Farinelli C; Gatto I; Biagioni E; Sarti M; Franceschini E; Meschiari M; Mussini C; Tonelli R; Clini E; Girardis M; Busani S; Modena Covid-Working Group
    Viruses; 2023 Nov; 15(11):. PubMed ID: 38005936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus reactivation in critically ill immunocompetent patients.
    Libert N; Bigaillon C; Chargari C; Bensalah M; Muller V; Merat S; de Rudnicki S
    Biomed J; 2015; 38(1):70-6. PubMed ID: 25179711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality.
    Gatto I; Biagioni E; Coloretti I; Farinelli C; Avoni C; Caciagli V; Busani S; Sarti M; Pecorari M; Gennari W; Guaraldi G; Franceschini E; Meschiari M; Mussini C; Tonelli R; Clini E; Cossarizza A; Girardis M;
    Intensive Care Med; 2022 Jun; 48(6):706-713. PubMed ID: 35583676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is cytomegalovirus reactivation increasing the mortality of patients with severe sepsis?
    Kalil AC; Florescu DF
    Crit Care; 2011; 15(2):138. PubMed ID: 21457496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and risk factors of cytomegalovirus reactivation in critically Ill patients with COVID-19 pneumonia.
    Tassaneeyasin T; Sungkanuparph S; Srichatrapimuk S; Charoensri A; Thammavaranucupt K; Jayanama K; Kirdlarp S
    PLoS One; 2024; 19(5):e0303995. PubMed ID: 38771836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and associations with clinical outcomes of cytomegalovirus reactivation after haploidentical versus matched-sibling unmanipulated PBSCT in patients with hematologic malignancies.
    Gao XN; Lin J; Wang LJ; Li F; Li HH; Wang SH; Huang WR; Gao CJ; Yu L; Liu DH
    Ann Hematol; 2020 Aug; 99(8):1883-1893. PubMed ID: 32572523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus Reactivation in Patients with Sepsis in an Intensive Care Unit in Portugal.
    Paixão P; Ramos P; Piedade C; Casado A; Chasqueira M
    Acta Med Port; 2020 Sep; 33(9):576-582. PubMed ID: 32498761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes simplex virus and Cytomegalovirus reactivation among severe ARDS patients under veno-venous ECMO.
    Hraiech S; Bonnardel E; Guervilly C; Fabre C; Loundou A; Forel JM; Adda M; Parzy G; Cavaille G; Coiffard B; Roch A; Papazian L
    Ann Intensive Care; 2019 Dec; 9(1):142. PubMed ID: 31872319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cytomegalovirus reactivation on the time course of systemic host response biomarkers in previously immunocompetent critically ill patients with sepsis: a matched cohort study.
    van de Groep K; Nierkens S; Cremer OL; Peelen LM; Klein Klouwenberg PMC; Schultz MJ; Hack CE; van der Poll T; Bonten MJM; Ong DSY;
    Crit Care; 2018 Dec; 22(1):348. PubMed ID: 30563551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus infection and outcome in immunocompetent patients in the intensive care unit: a systematic review and meta-analysis.
    Li X; Huang Y; Xu Z; Zhang R; Liu X; Li Y; Mao P
    BMC Infect Dis; 2018 Jun; 18(1):289. PubMed ID: 29954328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Antiviral Therapy for Prevention of Cytomegalovirus Reactivation in Immunocompetent Critically Ill Patients: A Randomized Clinical Trial.
    Cowley NJ; Owen A; Shiels SC; Millar J; Woolley R; Ives N; Osman H; Moss P; Bion JF
    JAMA Intern Med; 2017 Jun; 177(6):774-783. PubMed ID: 28437539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.